유전성 암 유전 상담을 위한 네 가지 가계도 작성 프로그램의 비교 평가 (Comparison of Four Pedigree-Generating Programs for Genetic Counseling of Hereditary Cancer)

EPCAM 생식세포 유전자 변이의 임상적 의의

포이츠-제거스 증후군에 대한 종합적 고찰: 유전학, 임상적 표현 및 관리 전략

Prevalence of germline CHEK2 variants in East Asians and Koreans based on population genomic databases

Causal Attributions in Patients With Breast and Gynecological Cancers: A Scoping Review

Protocol for generation and utilization of patient-derived organoids from multimodal specimen

Optimal Value of Mutant KRAS Circulating Tumor DNA for Predicting Prognosis and Monitoring in Patients with Pancreatic Adenocarcinoma: A Prospective Multicenter Cohort Study

Organoid morphology-guided classification for oral cancer reveals prognosis

Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer

Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study

PALB2 germline pathogenic variants: frequency, clinical features, and functional analysis of c.3350+5G>A variant in 3987 Korean cancer patients

Korean patients with hereditary cancer: a prospective multicentre cohort study protocol exploring psychosocial and health outcomes

미국국립종합암네트워크 가이드라인 유전적/가족력 고위험 평가: 유방, 난소 및 췌장 3.2024 버전의 주요 개정사항

ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer

Carrier Frequency and Incidence of MUTYH-Associated Polyposis Based on Database Analysis in East Asians and Koreans

Case report: Extraskeletal Ewing sarcoma with a germline pathogenic variant of SMARCA4

Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variant

PALB2 생식세포 병원성 유전자 변이의 임상적 의의 (Clinical Significance of PALB2 Pathogenic Germline Variant)

Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis

PRMT1 promotes pancreatic cancer development and resistance to chemotherapy